Teva Pharmaceuticals USA, Inc., (NYSE: TEVA) announced that they have settled the patent litigation with AstraZeneca Pharmaceuticals LP, AstraZeneca AB ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE